Dongkook, Yuhan and Celltrion Post Global Marketing, Donation Updates

Dongkook Pharmaceutical’s Centellian24 joins major global beauty expo

Dongkook Pharmaceutical’s dermacosmetic brand Centellian24 takes part in Cosmoprof Bologna 2026 in Bologna, Italy, March 26-29. [Photo=Dongkook Pharmaceutical]

Dongkook Pharmaceutical said its dermacosmetic brand Centellian24 participated in Cosmoprof Bologna 2026, billed as the world’s largest beauty trade show, held March 26-29 in Bologna, Italy.

Now in its 57th year, the event is a venue for sharing market trends and business opportunities. Organizers drew about 3,100 companies from more than 150 countries and more than 250,000 industry participants, the company said.

Centellian24 attended for a second straight year and ran a standalone booth to expand contact with global buyers. The booth featured hands-on demonstrations of key products including Madeca Cream Time Reverse; Expert Madeca Cream Active Renew PDRN; 360 Shot PDRN Active Serum; 360 Shot PDRN Lifting Eye Cream; 360 Shot PDRN Glowing Eye Patch; and the Madeca Prime Max beauty device.

Yuhan holds blood drive across sites to support supply and cancer patients

A Yuhan blood donation campaign vehicle. [Photo=Yuhan]

Yuhan said it ran a “blood donation campaign to save lives” across its operations, including its Daebang-dong headquarters as well as research facilities and plants, to help ease blood shortages and support cancer patients.

The campaign was held over three days — March 16, 17 and 20 — the company said. Yuhan has run the program since 2008 and holds it regularly twice a year, in the first and second halves.

A total of 71 employees participated this time, bringing cumulative participation to about 2,500, it said. Employees also donated blood donation certificates, which are to be used through the Korea Childhood Leukemia Foundation to support pediatric cancer patients who need transfusions.

Celltrion holds Brazil launch event for autoimmune drug Omliclo

Celltrion said it held a launch event in Brazil — the largest pharmaceutical market in Latin America — for Omliclo, an autoimmune disease treatment whose active ingredient is omalizumab.

About 80 people attended, including Brazilian specialists in allergy, respiratory medicine and dermatology, as well as representatives from insurers, the company said. Presentations covered Omliclo’s clinical data, global prescribing experience and its value in real-world care settings. Attendees showed strong interest in prescribing experience and expressed expectations for broader use, Celltrion said.

Celltrion’s Brazil unit has continued local marketing since launching Omliclo there in November. It recently won a bid from the Santa Catarina state government, securing an early supply channel, the company said. With Omliclo launched as a “first mover” in Brazil, Celltrion said it expects additional bid wins to continue.

Jaseng delivers rice donation in Busan and launches local volunteer group

Members of the newly launched Busan Jaseng Volunteer Group, totaling 21 people, pose for a commemorative photo with key officials. [Photo=Jaseng Korean Medicine Hospital]

Jaseng Medical Foundation said it delivered 480 bags of 10-kilogram white rice to the Busan Community Chest on March 30 to support food needs among vulnerable residents.

The Busan city government will assist with administrative support for recipients, while the Busan Community Chest will select households in need, the foundation said. Each selected household will receive 10 kilograms of rice, to be distributed through food banks and food markets across Busan’s 16 districts and counties.

A launch ceremony for the Busan Jaseng Volunteer Group was also held after the donation event. The group, formed with 21 members, is a private volunteer organization made up of local residents and aims to build sustained ties with the community, the foundation said. Busan Jaseng Korean Medicine Hospital will support its operations and activities.

* This article has been translated by AI.

Park boram